Robuta

Sponsor of the Day: Jerkmate
https://www.biospace.com/employer/400681/lundbeck Lundbeck - BioSpace lundbeckbiospace https://www.biospace.com/job-trends/9-companies-hiring-now-in-massachusetts 9 Companies Hiring Now in Massachusetts - BioSpace Aug 21, 2025 - Looking for a biopharma job in Massachusetts? Check out the BioSpace list of nine companies hiring life sciences professionals like you. 9 companies hiringmassachusetts biospace https://www.biospace.com/drug-development/the-next-phase-of-diabetes-care The next phase of diabetes care - BioSpace Apr 22, 2026 - As technology becomes more integrated and personalized, experts say the biggest opportunity in diabetes management is reducing everyday burdens. next phasediabetes carebiospace https://www.biospace.com/contact-us Contact Us - BioSpace usbiospace https://www.biospace.com/download-talent-solutions-media-kit Download Talent Solutions Media Kit - BioSpace Apr 23, 2026 - Learn more about how BioSpace can help you build your talent pipeline with a growing community of experienced life science professionals. talent solutionsmedia kitdownloadbiospace https://www.biospace.com/report-the-state-of-diversity-equity-inclusion-and-belonging-in-life-sciences Report: The State of Diversity, Equity, Inclusion and Belonging in Life Sciences - BioSpace Sep 26, 2024 - BioSpace's third report on diversity, equity, inclusion and belonging in life sciences examines dramatic shifts in attitude around diversity initiatives. diversity equity inclusionlife sciencesreportstatebelonging https://www.biospace.com/hotbeds Hotbeds - BioSpace Jan 1, 2026 - Explore BioSpace's Hotbed Maps, highlighting life sciences hotspots across the U.S. hotbedsbiospace https://www.biospace.com/fda/rare-disease-leaders-call-for-regulatory-clarity-as-fda-balances-urgency-with-rigor Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency With Rigor - BioSpace Apr 2, 2026 - With CBER director Vinay Prasad set to depart the agency at the end of the month, a coalition of patient groups and biotech executives penned a letter... rare diseaseleaders callregulatory clarityfdabalances https://www.biospace.com/genentech-to-present-positive-data-for-agressive-lymphoma-antibody-at-asco Genentech Announces Optimistic Data in Aggressive DLBCL - BioSpace May 27, 2022 - Genentech announced new data related to its investigational CD20xCD3 T-cell engaging bispecific antibody intended to treat relapsed or refractory diffuse large... genentechannouncesoptimisticdataaggressive https://www.biospace.com/series-a Series A - BioSpace seriesbiospace https://www.biospace.com/business/biontech-starts-shuttering-singapore-mrna-manufacturing-site-amid-pipeline-pivot BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot - BioSpace Apr 3, 2026 - BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other modalities while mRNA technology... manufacturing sitebiontechstartsshutteringsingapore https://www.biospace.com/career-advice/stop-selling-the-dream-start-telling-the-truth Stop Selling the Dream, Start Telling the Truth - BioSpace Sep 17, 2025 - Transparency doesn’t drive people away. It attracts the right ones and keeps them committed. Leadership coach Angela Justice discusses the problem with leaders... stop sellingtelling truthdreamstartbiospace https://www.biospace.com/fda/rezolute-lauds-unusual-fda-feedback-supportive-of-path-forward-for-hypoglycemia-drug Rezolute Lauds ‘Unusual’ FDA Feedback Supportive of Path Forward for Hypoglycemia Drug - BioSpace Mar 24, 2026 - While ersodetug missed the Phase 3 primary endpoint of a reduction in hypoglycemia events, Rezolute argued that this goal was confounded in part by behavioral... path forwarddrug biospacelaudsfdafeedback https://www.biospace.com/employer/397613/moderna-inc Moderna, Inc. - BioSpace moderna incbiospace https://www.biospace.com/rss-feeds RSS Feeds - BioSpace rss feedsbiospace https://www.biospace.com/clinical-catch-up-december-6-10 Clinical Catch-Up: December 6-10 - BioSpace Apr 3, 2026 - There were a lot of clinical trial announcements this week, driven by the European Society for Medical Oncology annual conference. Here’s a look. december 6clinicalcatch10biospace https://www.biospace.com/employer/3014776/light-horse-therapeutics Light Horse Therapeutics - BioSpace therapeutics biospacelighthorse https://www.biospace.com/business/5-pharma-powerhouses-facing-massive-patent-cliffs-and-what-theyre-doing-about-it 5 Pharma Powerhouses Facing Massive Patent Cliffs—And What They’re Doing About It - BioSpace Feb 19, 2025 - Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of the industry’s top-performers are... 5pharmapowerhousesfacingmassive https://www.biospace.com/terms-and-conditions Terms and Conditions - BioSpace termsconditionsbiospace https://www.biospace.com/business/gossamer-nearly-halves-workforce-in-savings-push-after-late-stage-hypertension-fail Gossamer Nearly Halves Workforce in Savings Push After Late-Stage Hypertension Fail - BioSpace Mar 20, 2026 - Gossamer Bio reported last month that its only late-stage candidate failed a Phase 3 study in pulmonary arterial hypertension, casting doubt on the asset's... late stagegossamernearlyhalvesworkforce https://www.biospace.com/employer/394752/anaptysbio-inc AnaptysBio, Inc. - BioSpace inc biospace https://www.biospace.com/employer/549539/legend-biotech Legend Biotech - BioSpace legendbiotechbiospace https://www.biospace.com/civica-rx-plans-to-provide-insulin-at-no-more-than-30-per-vial Civica Plans to Provide Insulin at No More than $30 per Vial - BioSpace Mar 3, 2022 - At this time, Civica plans a recommended price to the consumer of no more than $30 per vial and no more than $55 for a box of five pen cartridges. It believes... 30 percivicaplansprovideinsulin https://www.biospace.com/drug-development/aacr-2026-moderna-revolution-zymeworks-and-beone-showcase-new-data AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data - BioSpace Apr 21, 2026 - Moderna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer. aacr 2026showcase newdata biospacemodernarevolution https://www.biospace.com/employer/2812917/apogee-therapeutics Apogee Therapeutics - BioSpace therapeutics biospaceapogee https://www.biospace.com/drug-development/biospaces-nextgen-class-of-2025-leans-into-biopharmas-hottest-trends BioSpace’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends - BioSpace Jan 29, 2025 - From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic... nextgen classhottest trends2025leansbiospace https://www.biospace.com/career-advice/9-companies-hiring-quality-control-jobs 9 Companies Hiring Quality Control Jobs - BioSpace Aug 1, 2024 - Looking for a quality control job? Check out these nine companies hiring life sciences professionals like you. 9 companies hiringquality controljobs biospace https://www.biospace.com/drug-development/sanas-cell-therapy-sustains-insulin-production-through-14-months-in-a-t1d-patient Sana’s Cell Therapy Sustains Insulin Production Through 14 Months in a T1D Patient - BioSpace Mar 18, 2026 - Sana Biotechnology is looking to start clinical development for its type 1 diabetes therapy SC451 this year. cell therapy14 monthssustainsinsulinproduction https://www.biospace.com/william-eberley William Eberley - BioSpace Vertex Pharmaceuticals williambiospace https://www.biospace.com/denatured Denatured - BioSpace Jun 10, 2025 - Join BioSpace Insights and guests as we dive into the biggest challenges facing biopharma, whether it's diversity in clinical trials, artificial intelligence... denaturedbiospace https://www.biospace.com/policy/moderna-notches-much-needed-win-in-covid-19-patent-spat-with-roivant Moderna Notches Much-Needed Win in COVID-19 Patent Spat With Roivant - BioSpace Mar 4, 2026 - The settlement, which requires Moderna to pay the plaintiffs $950 million upfront plus up to $1.3 billion in contingent commitments, is an outcome “better than... much neededcovid 19modernanotcheswin https://www.biospace.com/business/nonprofit-aims-to-modernize-manufacturing-by-clearing-capital-hurdle Nonprofit Aims To Modernize Manufacturing by Clearing Capital Hurdle - BioSpace Mar 10, 2026 - Industry groups have identified upfront costs as a barrier to streamlining U.S. drugmaking. The nonprofit API Innovation Center has a proposed answer for how... nonprofitaimsmodernizemanufacturingclearing https://www.biospace.com/jennifer-doudna-s-mammoth-connects-with-vertex-to-leverage-ultra-small-crispr-systems Jennifer Doudna’s Mammoth Links with Vertex in $700 Million Ultra-Small CRISPR Deal - BioSpace Oct 28, 2021 - Mammoth Biosciences just announced a collaboration with Vertex to develop in vivo gene-editing therapeutics for patients with either of two serious, but... 700 millionultra smalljennifermammothlinks https://www.biospace.com/gene-editing Gene editing - BioSpace gene editingbiospace https://www.biospace.com/business/opinion-the-high-stakes-tradeoffs-of-a-most-favored-nation-drug-policy The High Stakes Tradeoffs of a Most Favored Nation Drug Policy - BioSpace Aug 13, 2025 - President Donald Trump loves a deal, but Most Favored Nation drug pricing isn't a good one for anyone. favored nation drughigh stakestradeoffspolicybiospace https://www.biospace.com/compensation Compensation - BioSpace compensationbiospace https://www.biospace.com/business/tang-capitals-concentra-on-buyout-binge-with-plenty-of-biotech-fodder Tang Capital’s Concentra on Buyout Binge With Plenty of Biotech Fodder - BioSpace Aug 13, 2025 - After a slow 2024, the biotech shell company Concentra Biosciences is back, offering to buy four biotechs in the past month and seven so far this year. tangconcentrabuyoutbingeplenty https://www.biospace.com/government Government - BioSpace governmentbiospace https://www.biospace.com/biospace-editorial-staff BioSpace Editorial Staff - BioSpace editorial staffbiospace https://www.biospace.com/jacob-donoghue Jacob Donoghue - BioSpace jacobdonoghuebiospace https://www.biospace.com/job-trends/2025-q4-job-market-report-positive-signs-emerge-for-job-seekers 2025 Q4 Job Market Report: Positive Signs Emerge for Job Seekers - BioSpace Feb 16, 2026 - BioSpace data show job postings live increased quarter over quarter, while layoffs fell year over year. job market report2025 q4positivesignsemerge https://www.biospace.com/companies Companies - BioSpace Jan 7, 2026 - Dive into news, jobs and get insights on life sciences companies across the U.S. companiesbiospace https://www.biospace.com/people People - BioSpace peoplebiospace https://www.biospace.com/opinion-column Opinion - BioSpace opinionbiospace https://www.biospace.com/manufacturing Manufacturing - BioSpace manufacturingbiospace https://www.biospace.com/jef-akst Jef Akst - BioSpace Mar 10, 2026 - Jef Akst is managing editor of BioSpace. You can reach her at jef.akst@biospace.com. Follow her on LinkedIn and Twitter @JefAkst. jefbiospace https://www.biospace.com/business/weight-loss-drama-compounds-on-heels-of-novo-lilly-earnings-plus-gene-therapy-news Weight Loss Drama Compounds on Heels of Novo, Lilly Earnings, Plus Gene Therapy News - BioSpace gene therapy newsweight lossdramacompoundsheels https://www.biospace.com/drug-development/new-wave-of-als-therapies-signals-renaissance-after-incremental-regression New Wave of ALS Therapies Signals Renaissance After Incremental Regression - BioSpace Sep 2, 2025 - After a demoralizing period punctuated by the withdrawal of one of the few marketed therapies for ALS, investment in new biotechs, state-backed collaborative... new wavealstherapiesrenaissanceincremental https://www.biospace.com/employer/540720/amneal-pharmaceuticals Amneal Pharmaceuticals - BioSpace pharmaceuticals biospaceamneal https://www.biospace.com/policy/uncertainty-looms-over-pharmas-legal-strategy-as-states-challenge-new-vaccine-schedule Uncertainty Looms Over Pharma’s Legal Strategy as States Challenge New Vaccine Schedule - BioSpace Mar 4, 2026 - The CDC’s changes threaten to cut vaccine sales for makers including Pfizer, Moderna, Merck and more, but a legal expert suspects affected manufacturers will... uncertainty loomslegal strategystates challengenew vaccineschedule https://www.biospace.com/fda/opinion-rare-disease-patients-cant-wait-for-regulatory-process Rare Disease Patients Can't Wait for Regulatory Process - BioSpace Mar 11, 2026 - The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay Prasad will help clear the path. rare disease patientsregulatory processwaitbiospace https://www.biospace.com/angela-gabriel Angela Gabriel - BioSpace Aug 4, 2025 - Angela Gabriel is content manager, life sciences careers, at BioSpace. She covers the biopharma job market, job trends and career advice, and produces client... angelagabrielbiospace https://www.biospace.com/job-trends/7-companies-hiring-in-new-york 7 Companies Hiring in New York - BioSpace May 29, 2025 - Looking for a biopharma job in New York? Check out the BioSpace list of seven companies hiring life sciences professionals like you. 7 companies hiringnew york biospace https://www.biospace.com/business/servier-adds-to-childhood-brain-tumor-portfolio-with-2-5b-day-one-buy Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy - BioSpace Mar 6, 2026 - Servier will pick up Ojemda, which received FDA approval in 2024 to treat pediatric glioma. The drug clocked sales of $155 million for Day One... childhood brain2 5bday oneservieradds https://www.biospace.com/clinical-research Clinical research - BioSpace clinical researchbiospace https://www.biospace.com/?p=00000190-3b6c-d37a-adf7-3becc0d50000.2 BioSpace: Biotech, Pharmaceutical and Clinical Research News clinical research newsbiospace biotechpharmaceutical https://employer.biospace.com/static-page/240/contact-us/ BioSpace | Employer Services employer servicesbiospace https://www.biospace.com/employer/3014764/bambusa-therapeutics Bambusa Therapeutics - BioSpace therapeutics biospace https://www.biospace.com/career-advice/job-hugging-wont-save-you-the-hidden-risk-of-playing-it-safe Job Hugging Won’t Save You: The Hidden Risk of Playing It Safe - BioSpace Oct 15, 2025 - In a volatile industry, staying put might seem like a smart bet, but job hugging can quietly erode your visibility, growth and future opportunities. hidden riskjobhuggingsaveplaying https://www.biospace.com/drug-development/kardigan-blood-pressure-drug-proves-hypothesis-despite-split-phase-2-readout Kardigan Blood Pressure Drug Proves Hypothesis Despite Split Phase 2 Readout - BioSpace Mar 30, 2026 - While tonlamarsen missed one of two co-primary endpoints, Kardigan says the drug has shown a clinically meaningful effect on blood pressure, supporting... blood pressuresplit phasekardigandrugproves https://www.biospace.com/policy Biopharma Policy News - BioSpace policy newsbiopharmabiospace https://www.biospace.com/employer/2812901/tr1x-bio Tr1X - BioSpace biospace https://www.biospace.com/drug-development/beyond-buzzwords-in-longevity-investing Beyond Buzzwords in Longevity Investing - BioSpace Mar 26, 2026 - In this episode of Denatured, you'll listen to Sergey Jakimov, managing partner at LongeVC and Artem Trotsyuk, operating partner, US, LongeVC. We speak about... beyond buzzwordslongevity investingbiospace https://www.biospace.com/employer/546333/faraday-pharmaceuticals Faraday Pharmaceuticals - BioSpace pharmaceuticals biospacefaraday https://www.biospace.com/job-trends/6-companies-hiring-now-in-boston 6 Companies Hiring Now in Boston - BioSpace Oct 2, 2025 - Looking for a biopharma job in Boston? Check out the BioSpace list of six companies hiring life sciences professionals like you. 6 companies hiringbostonbiospace https://www.biospace.com/fda/fdas-bespoke-pathway-to-focus-on-gene-editing-and-rna-based-treatments-for-rare-diseases FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases - BioSpace Feb 24, 2026 - The framework, first introduced by FDA Commissioner Marty Makary and Center for Biologics Evaluation and Research head Vinay Prasad in November, was criticized... gene editingrna basedrare diseasesbespokepathway https://www.biospace.com/policy/former-emergent-ceo-hit-with-insider-trading-lawsuit Former Emergent CEO Hit With Insider Trading Lawsuit - BioSpace Jan 16, 2026 - Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with information related to the company’s... insider tradingformeremergentceohit https://www.biospace.com/employer/44933/astrazeneca-pharmaceuticals-lp AstraZeneca Pharmaceuticals LP - BioSpace astrazenecapharmaceuticalslpbiospace https://www.biospace.com/events/webinar-shifting-risk-biopharma-in-an-age-of-deregulation Webinar: Shifting Risk | Biopharma in an Age of Deregulation - BioSpace Nov 3, 2025 - During this webinar BioSpace sits down with former FDA Chief Information Officer Vid Desai to discuss the potential advantages and pitfalls of deregulation... webinarshiftingriskbiopharmaage https://www.biospace.com/job-trends/9-companies-hiring-now-in-pennsylvania 9 Companies Hiring Now in Pennsylvania - BioSpace Feb 19, 2026 - Looking for a biopharma job in Pennsylvania? Check out the BioSpace list of nine companies hiring life sciences professionals like you. 9 companies hiringpennsylvaniabiospace https://www.biospace.com/best-places-to-work Best Places to Work - BioSpace best placesworkbiospace https://www.biospace.com/employer/2881096/mirador-therapeutics-inc Mirador Therapeutics, Inc. - BioSpace therapeutics incmiradorbiospace https://www.biospace.com/employer/537761/modex-therapeutics Modex Therapeutics - BioSpace therapeutics biospacemodex https://www.biospace.com/genetown Genetown - BioSpace biospace https://www.biospace.com/patents Patents - BioSpace patentsbiospace https://www.biospace.com/drug-development/validated-mechanisms-strong-data-beat-hype-in-longevity-investing Validated Mechanisms, Strong Data Beat Hype in Longevity Investing - BioSpace Mar 24, 2026 - Longevity is a long-standing buzzword in life sciences, but it now has staying power. The smart trajectory is to stop chasing aging as an abstract target and... strong datalongevity investingvalidatedmechanismsbeat https://www.biospace.com/employer/548162/visterra-inc Visterra, Inc. - BioSpace inc biospace https://www.biospace.com/job-trends/gilead-and-kite-are-cutting-employees-closing-seattle-philadelphia-sites Gilead and Kite Are Cutting Employees, Closing Seattle, Philadelphia Sites - BioSpace Nov 18, 2024 - Gilead’s layoffs include 72 employees at its Seattle location, which will close. Kite will shut down its Philadelphia facility. The layoffs are attributed to... gileadkitecuttingemployeesclosing https://www.biospace.com/career-advice/when-feedback-feels-off-using-critique-that-doesnt-feel-fair When Feedback Feels Off: Using Critique That Doesn’t Feel Fair - BioSpace Jul 16, 2025 - It’s easy to get caught up in defending yourself against critique that feels unfair. Leadership coach Angela Justice recommends a different approach that can... feedbackfeelsusingcritiquefair https://www.biospace.com/job-trends/takeda-restructuring-could-push-more-than-600-us-staffers-out-of-jobs Takeda Restructuring Could Push More Than 600 US Staffers Out of Jobs - BioSpace Mar 30, 2026 - Takeda’s layoffs include cutting 247 people in Massachusetts. The workforce reduction is meant to help offset investments in areas including a product launch... could pushjobs biospacetakedarestructuring600 https://www.biospace.com/pharm-country Pharm Country - BioSpace Jan 1, 2026 - Connecticut, New York, New Jersey, Pennsylvania and Rhode Island pharmcountrybiospace https://www.biospace.com/niels-vande-casteele Niels Vande Casteele - BioSpace Mirador Therapeutics nielsvandebiospace https://www.biospace.com/talk-to-sales Talk to Sales - BioSpace Feb 7, 2025 - Get in touch with our sales team to discuss how BioSpace can help you meet your business goals, whether it's advertising, recruitment marketing or thought... talksalesbiospace https://www.biospace.com/job-trends/7-companies-hiring-in-north-carolina 7 Companies Hiring in North Carolina - BioSpace Jul 31, 2025 - Looking for a biopharma job in North Carolina? Check out the BioSpace list of seven companies hiring life sciences professionals like you. 7 companies hiringnorth carolinabiospace https://www.biospace.com/glp-1 GLP-1 - BioSpace glp 1biospace https://www.biospace.com/employer/2437766/a-stealth-startup-biotech-company Arnatar Therapeutics - BioSpace therapeutics biospace https://www.biospace.com/business/revolution-knows-its-worth-as-merck-backs-off-for-now Revolution Knows Its Worth as Merck Backs Off—For Now - BioSpace Jan 27, 2026 - Investors are apparently taking bets on when Revolution will be acquired. A handful of pharmas could be interested as Merck backs off. revolutionknowsworthmerckbacks https://www.biospace.com/events/webinar-the-future-is-collaborative-transforming-clinical-trials Webinar: The Future is Collaborative: Transforming Clinical Trials - BioSpace Mar 3, 2026 - This webinar explores how collaborative-initiated trials and Investigator-Initiated Trials (IITs) are complementing traditional drug development to accelerate... transforming clinical trialswebinarfuturecollaborativebiospace https://www.biospace.com/david-de-vries David de Vries - BioSpace david devriesbiospace https://www.biospace.com/regulatory Regulatory - BioSpace regulatorybiospace https://www.biospace.com/employer/539922/arvinas-inc Arvinas Inc. - BioSpace inc biospacearvinas https://www.biospace.com/business/moderna-wont-run-phase-iii-vaccine-trials-as-skepticism-grows-in-us-bloomberg Moderna Won’t Run Phase III Vaccine Trials as Skepticism Grows in US: Bloomberg - BioSpace Jan 23, 2026 - Growing opposition to vaccines in the U.S., driven by recent government policy changes, makes it difficult to see a return on investment in vaccine... phase iiivaccine trialsmodernarunskepticism https://www.biospace.com/drug-development/structure-climbs-on-highly-competitive-profile-for-weight-loss-pill Structure Climbs on ‘Highly Competitive’ Profile for Weight Loss Pill - BioSpace Mar 16, 2026 - Structure Therapeutics’ oral obesity drug elicited a placebo-adjusted weight loss of 16.3% at 44 weeks in a Phase 2 trial. The biotech is planning to launch a... weight loss pillstructureclimbsprofilebiospace https://www.biospace.com/evan-feinberg Evan Feinberg - BioSpace Genesis Therapeutics evanfeinbergbiospace https://www.biospace.com/job-trends/9-companies-hiring-in-oncology 9 Companies Hiring in Oncology - BioSpace Oct 9, 2025 - Looking for a job in oncology? Check out the BioSpace list of nine companies hiring life sciences professionals like you. 9 companies hiringoncologybiospace https://www.biospace.com/drug-development/pfizers-ibrance-heir-reduces-risk-of-death-in-phase-2-breast-cancer-test Pfizer’s Ibrance Heir Reduces Risk of Death in Phase 2 Breast Cancer Test - BioSpace Mar 17, 2026 - Pfizer has a lofty goal for the CDK4 inhibitor atirmociclib, the New York pharma’s answer to Ibrance’s loss of patent protection next year. In 2025, Ibrance... reduces riskphase 2breast cancerheirdeath https://www.biospace.com/job-trends/11-companies-hiring-now-in-new-york 11 Companies Hiring Now in New York - BioSpace Mar 25, 2026 - Looking for a biopharma job in New York? Check out the BioSpace list of 11 companies hiring life sciences professionals like you. 11 companies hiringnew york biospace https://www.biospace.com/business/novartis-pledges-480m-to-expand-china-presence-following-eli-lilly-and-astrazeneca Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca - BioSpace Mar 24, 2026 - Like its pharma peers, Novartis is pouring money into Chinese operations, including expansions and upgrades at an existing manufacturing facility. china presenceeli lillynovartispledgesexpand https://www.biospace.com/angela-yen Angela Yen - BioSpace Vertex Pharmaceuticals angelayenbiospace https://www.biospace.com/job-trends/9-companies-hiring-in-new-jersey 9 Companies Hiring in New Jersey - BioSpace Dec 11, 2025 - Looking for a new opportunity in New Jersey? These nine companies have open roles that could be a great fit for you. 9 companies hiringnew jerseybiospace